Detecting Recurrent Prostate Cancer With 11C-choline Positron Emission Tomography
NCT02531672 · Status: NO_LONGER_AVAILABLE · Type: EXPANDED_ACCESS
Last updated 2020-06-05
Summary
The purpose of this study is to use a new imaging drug called 11C-choline that is used with a PET/CT scan to see prostate cancer when it cannot be seen well on other scans, such as bone scans, CT or MRI.
Conditions
- Prostate Cancer
- Recurrent Prostate Cancer
Interventions
- DRUG
-
11C-choline
- DEVICE
-
PET/CT Scan
Sponsors & Collaborators
-
Memorial Sloan Kettering Cancer Center
lead OTHER
Principal Investigators
-
Heiko Schӧder, MD · Memorial Sloan Kettering Cancer Center
Eligibility
- Min Age
- 18 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
Countries
- United States
Study Locations
More Related Trials
-
Irinotecan in Treating Patients With Metastatic or Recurrent Colorectal Cancer
NCT00002933 ·Status: COMPLETED ·Phase: PHASE2
-
Nivolumab in Patients With High-Risk Biochemically Recurrent Prostate Cancer
NCT03637543 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Study to Assess the Safety and Efficacy of Intravenous Injection of the Imaging Agent 111In-IPN01087 in Patients With Locally Advanced or Metastatic Pancreatic or Colorectal Cancer.
NCT04632199 ·Status: WITHDRAWN ·Phase: PHASE1
-
An Observational Study of Avastin (Bevacizumab) in Patients With Metastatic Colorectal Cancer (ACORN)
NCT01506167 ·Status: COMPLETED
-
S9923 R115777 in Treating Patients With Advanced Colorectal Cancer
NCT00005833 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Xeloda (Capecitabine) in Patients With Advanced and/or Metastatic Colorectal Cancer
NCT00048126 ·Status: COMPLETED ·Phase: PHASE2
-
An Observational Study of Avastin in Participants With Metastatic Colorectal Cancer (KORALLE)
NCT01775644 ·Status: COMPLETED
-
Irinotecan, Capecitabine and Avastin for Metastatic Colorectal Cancer as Salvage Treatment
NCT00717990 ·Status: TERMINATED ·Phase: PHASE2
-
An Observational Study of First-Line Bevacizumab (Avastin) With Fluoropyrimidine-Based Chemotherapy in Participants With Metastatic Colorectal Cancer
NCT01712347 ·Status: COMPLETED
-
Image Guided Treatment Optimization With Cetuximab for Patients With Metastatic Colorectal Cancer
NCT02117466 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
To Determine the Safety of Regorafenib, Hydroxychloroquine, and Entinostat Metastatic Colorectal Cancer
NCT03215264 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase I Study of MLN6907 in Patients With Metastatic Colorectal
NCT02056015 ·Status: COMPLETED ·Phase: PHASE1
-
Visualization of Anti-angiogenic Effects With Perfusion Computed Tomography (CTP)
NCT02511756 ·Status: TERMINATED ·Phase: NA
-
Botensilimab, Balstilimab and Regorafenib or Botensilimab and Balstilimab for the Treatment of Advanced or Metastatic Microsatellite Stable Colorectal Cancer
NCT06575725 ·Status: WITHDRAWN ·Phase: PHASE2
-
Ro 31-7453 in Treating Patients With Recurrent or Refractory Metastatic Colorectal Cancer
NCT00016250 ·Status: COMPLETED ·Phase: PHASE2
-
First-Line FOLFOX-Bevacizumab for Advanced Colorectal Cancer With Wild-Type Ras
NCT01057017 ·Status: TERMINATED ·Phase: PHASE2
-
Nintedanib and Capecitabine in Treating Patients With Refractory Metastatic Colorectal Cancer
NCT02393755 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Minimal Residual Disease Testing for the Early Detection of Cancer Recurrence in Resectable Stage II-IV Colorectal Cancer Patients
NCT07125729 ·Status: RECRUITING ·Phase: NA
-
A Study of Bevacizumab (Avastin) in Combination With Chemotherapy in Participants With Metastatic Cancer of the Colon or Rectum
NCT02582970 ·Status: COMPLETED ·Phase: PHASE4
-
Observation of Patients With Metastatic Colorectal Cancer Starting Chemotherapy Combined With Bevacizumab (Avastin)
NCT02612077 ·Status: COMPLETED
-
Bemalenograstim Alfa for the Prevention in Patients With Colorectal Cancer/Pancreatic Cancer
NCT06134765 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
BMS-247550 in Treating Patients With Recurrent or Metastatic Colorectal Cancer
NCT00022477 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Avastin With Chemotherapy for Treatment of Metastatic or Advanced and Unresectable Colorectal Adenocarcinoma
NCT00097578 ·Status: COMPLETED
-
STIL101 for Injection for the Treatment of Locally Advanced, Metastatic or Unresectable Pancreatic Cancer, Colorectal Cancer, Renal Cell Cancer, Cervical Cancer and Melanoma
NCT06626256 ·Status: WITHDRAWN ·Phase: PHASE1
-
Investigating Cabozantinib in Patients With Refractory Metastatic Colorectal Cancer
NCT03542877 ·Status: COMPLETED ·Phase: PHASE2